Revance therapeutics, inc. sued for securities law violations - investors should contact the gross law firm for more information - rvnc

New york , feb. 24, 2025 /prnewswire/ -- the gross law firm issues the following notice to shareholders of revance therapeutics, inc. (nasdaq: rvnc). shareholders who purchased shares of rvnc during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

RVNC Ratings Summary

RVNC Quant Ranking